Increasing drug users' adherence to HIV treatment: Results of a peer-driven intervention feasibility study

Social Science and Medicine

Volumn 55, Issue 2, 2002, Pages 235-246

  Broadhead, Robert S ^a   Heckathorn, Douglas D ^b   Altice, Frederick L ^c   Van Hulst, Yaël ^a   Carbone, Michael ^c   Friedland, Gerald H ^c   O'Connor, Patrick G ^c   Selwyn, Peter A ^d  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adherence; Antiretroviral therapy; Health care utilization; HIV AIDS; Injecting drug users; Intervention; Social supports; Substance abuse; USA

Indexed keywords

ANTIRETROVIRUS AGENT;

DRUG USER;

ADULT; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CONTROLLED STUDY; COUNSELING; DRUG USE; FEASIBILITY STUDY; FEMALE; GROUP PSYCHOLOGY; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIMARY MEDICAL CARE; SUPPORT GROUP; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMMUNITY-INSTITUTIONAL RELATIONS; CONNECTICUT; FEASIBILITY STUDIES; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; PEER GROUP; SELF-HELP GROUPS; SOCIAL SUPPORT; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0036281388     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(01)00167-8     Document Type: Article

References (59)

1. The era of adherence to antiretroviral therapy
2. The forms of capital
3. Takin it to the streets: AIDS outreach as ethnography
4. Occupational health risks of harm reduction work: Combating aids among injection drug users
5. AIDS prevention outreach among injection drug users: Agency problems and new approaches
6. Drug users versus outreach workers in combating AIDS: Preliminary results of a peer-driven intervention
7. Harnessing peer networks as an instrument for AIDS prevention: Results from a peer-driven intervention
8. Enrollment of drug abusers in HIV clinical trials: A pubic health imperative for communities of color
9. Participation in an outreach-based coupon distribution program for free methadone detoxification
10. Self-reported antiretroviral therapy in injection drug users
11. The medical complications of drug addiction and the medical assessment of the IV drug user: Twenty-five years later
12. Social capital in the creation of human capital
13. The sharing of drug injection equipment and the AIDS epidemic in New York City
14. The ethnography of needle sharing among intravenous drug users and implications for public policies and intervention strategies
15. Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program
16. Reaching the unreached: Targeting hidden IDU populations with clean needles via known users
17. Infectious diseases and drug abuse: Prevention and treatment in the drug abuse treatment system
18. A critical review of interventions to improve compliance with prescribed medications
19. Collective sanctions and compliance norms: A formal theory of group-mediated social control
20. Rational choice, public policy and AIDS
21. AIDS and social networks: Prevention through network mobilization
22. Proactive and reactive strategies for delivering community based HIV prevention services: An ethnographic analysis
23. Behavioral theories and the problem of compliance
24. Health education for hypertensive patients
25. The major medical complications of narcotic addiction
26. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions
27. Zidovudine therapy and health resource utilization in AIDS
28. Variation in health service use among HIV-infected patients
29. Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correction facility
30. Increasing compliance: Patient-operated hypertension groups
31. Human immunodeficiency virus infection in intravenous drug users: A model for primary care
32. Medical care for injection drug users with human immunodeficiency virus infection
33. Tuberculosis chemoprophylaxis using a liquid isoniazid-methadone admixture for drug users in methadone maintenance
34. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
35. How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMS caps
36. Trillion virion delay: Time from testing positive for HIV to presentation for primary care
37. The narcotic addict as a medical patient
38. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection
39. Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program
40. Primary care for patients with human immunodificiency virus (HIV) infection in a methadone maintenance treatment program
41. Utilization of health services in a cohort of intravenous drug users with known HIV-1serostatus
42. Barriers to use of free antiretroviral therapy in injection drug users
43. Providing medical care to methadone clinic patients: Referral vs. on-site care
44. Update: Trends in AIDS incidence-United States 1996
45. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality
46. The public health implications of antiretroviral therapy and drug resistance
47. Combining ethnographic and epidemiologic methods in targeted aids interventions: The Chicago model